Fig. 3From: Real-world use of ACEI/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcomePercentages of patients with SAP, UAP and AMI in 2 groups. SAP stable angina pectoris, UAP unstable angina pectoris, AMI acute myocardial infarction, ACEI/ARB angiotensin-converting enzyme inhibitor/angiotensin receptor blocker. *P < 0.05 versus ACEI/ARB(-) groupBack to article page